Inflammopharmacology

Aims & Scope

Inflammopharmacology is the official publication of the Gastrointestinal Section of the International Union of Basic and Clinical Pharmacology (IUPHAR) and the Hungarian Experimental and Clinical Pharmacology Society (HECPS).

Inflammopharmacology publishes papers on all aspects of inflammation and its pharmacological control emphasizing comparisons of (a) different inflammatory states, and (b) the actions, therapeutic efficacy and safety of drugs employed in the treatment of inflammatory conditions.

The comparative aspects of the types of inflammatory conditions include gastrointestinal disease (e.g. ulcerative colitis, Crohn's disease), parasitic diseases, toxicological manifestations of the effects of drugs and environmental agents, arthritic conditions, and inflammatory effects of injury or aging on skeletal muscle.

The journal has seven main interest areas: -Drug-Disease Interactions - Conditional Pharmacology - i.e. where the condition (disease or stress state) influences the therapeutic response and side (adverse) effects from anti-inflammatory drugs.

Mechanisms of drug-disease and drug disease interactions and the role of different stress states -Rheumatology - particular emphasis on methods of measurement of clinical response effects of new agents, adverse effects from anti-rheumatic drugs -Gastroenterology - with particular emphasis on animal and human models, mechanisms of mucosal inflammation and ulceration and effects of novel and established anti-ulcer, anti-inflammatory agents, or antiparasitic agents -Neuro-Inflammation and Pain - model systems, pharmacology of new analgesic agents and mechanisms of neuro-inflammation and pain -Novel drugs, natural products and nutraceuticals - and their effects on inflammatory processes, especially where there are indications of novel modes action compared with conventional drugs e.g.

NSAIDs -Muscle-immune interactions during inflammation [...]

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	5.3
2024	4.60

Journal Rank

Year	Value
2024	3214

Journal Citation Indicator

Year	Value
2024	3205

SJR (SCImago Journal Rank)

Year	Value
2024	1.269

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	74

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology, Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Role of nitric oxide in inflammatory diseases

  Citation: 1168

  Authors: J. N., A., S. S.

• Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling

  Citation: 544

  Authors: Magdalena, Magdalena, Gabriela, Katarzyna, Tadeusz

• Selenium and selenoproteins: it’s role in regulation of inflammation

  Citation: 510

  Authors: Sneha, Selvakumar

• The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings

  Citation: 488

  Authors: Garry G., Michael J., Richard O., Anthoulla, Kieran F.

• Ibuprofen: pharmacology, efficacy and safety

  Citation: 481

  Authors: K. D.

• Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases

  Citation: 430

  Authors: K. D., Ann L., Matthew, W. F.

• Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease

  Citation: 387

  Authors: Darshpreet, Vivek, Rahul

• Phenolic compounds in olive oil: antioxidant, health and organoleptic activities according to their chemical structure

  Citation: 335

  Authors: M., S., R., S., A., F., R., G. F.

• Cellular signalling pathways mediating the pathogenesis of chronic inflammatory respiratory diseases: an update

  Citation: 294

  Authors: Meenu, Daljeet S., Keshav R., Bhupender, Gaurav, S., Lakshmi, Murtaza M., Hamid A., Dinesh K., Parijat, Harish, Nitin B., Sachin K., Shakti D., Srinivas, Alaa A., Peter R., Philip M., Saurabh, Kamal

• Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer’s disease

  Citation: 286

  Authors: Rishika, Subhendu Shekhar, Phulen, Anusuya, Bikash, Dibbanti HariKrishna

---